The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
Open accessAbstract
BACKGROUND: Although the short-term benefits of bilateral stimulation of the subthalamic nucleus in patients with advanced Parkinson's disease have been well documented, the long-term outcomes of the procedure are unknown. METHODS: We conducted a five-year prospective study of the first 49 consecutive patients whom we treated with bilateral stimulation of the subthalamic nucleus. Patients were assessed at one, three, and five years with levodopa (on medication) and without levodopa (off medication), with use of the Unified Parkinson's Disease Rating Scale. Seven patients did not complete the study: three died, and four were lost to follow-up. RESULTS: As compared with base line, the patients' scores at five years for motor function while off medication improved by 54 percent (P<0.001) and those for activities of daily living improved by 49 percent (P<0.001). Speech was the only motor function for which off-medication scores did not improve. The scores for motor function on medication did not improve one year after surgery, except for the dyskinesia scores. On-medication akinesia, speech, postural stability, and freezing of gait worsened between year 1 and year 5 (P<0.001 for all comparisons). At five years, the dose of dopaminergic treatment and the duration and severity of levodopa-induced dyskinesia were reduced, as compared with base line (P<0.001 for each comparison). The average scores for cognitive performance remained unchanged, but dementia developed in three patients after three years. Mean depression scores remained unchanged. Severe adverse events included a large intracerebral hemorrhage in one patient. One patient committed suicide. CONCLUSIONS: Patients with advanced Parkinson's disease who were treated with bilateral stimulation of the subthalamic nucleus had marked improvements over five years in motor function while off medication and in dyskinesia while on medication. There was no control group, but worsening of akinesia, speech, postural stability, freezing of gait, and cognitive function between the first and the fifth year is consistent with the natural history of Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
Unified Parkinson's Disease Rating Scale
(2012) · SpringerReference · doi:10.1007/springerreference_184495 · Cited by 3,066
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W.-Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J. Q., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441002 · Cited by 2,366
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
Limousin, P., Krack, P., Pollak, P., Benazzouz, A., Ardouin, C., Hoffmann, D., & Benabid, A.-L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810153391603 · Cited by 1,853
Self-citation(2001) · New England Journal of Medicine · doi:10.1056/nejmoa000827 · Cited by 1,514
Core assessment program for intracerebral transplantations (CAPIT)
Langston, J. W., Widner, H., Goetz, C. G., Brooks, D., Fahn, S., Freeman, T., & Watts, R. (1992) · Movement Disorders · doi:10.1002/mds.870070103 · Cited by 1,008
Kumar, R., Lozano, A. M., Kim, Y. J., Hutchison, W. D., Sime, E., Halket, E., & Lang, A. E. (1998) · Neurology · doi:10.1212/wnl.51.3.850 · Cited by 634
Differential diagnosis and classification of apathy
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.1.22 · Cited by 620
Cited by
Items 101–116 of 116
Wenger, N., Moraud, E. M., Raspopovic, S., Bonizzato, M., DiGiovanna, J., Musienko, P., Morari, M., Micera, S., & Courtine, G. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008325 · Cited by 209
“ternational Conference on Rehabilitation Robotics (ICORR), Seattle, WA, 24 to 26 June 2013. 25. D. A.McCrea, Spinal circuitry of sensorimotor control of locomotion. J. Physiol.533, 41–50 (2001). 26.”
BackgroundRecent Advances in Materials, Devices, and Systems for Neural Interfaces
Won, S. M., Song, E., Zhao, J., Li, J., Rivnay, J., & Rogers, J. A. (2018) · Advanced Materials · doi:10.1002/adma.201800534 · Cited by 206
Herman, T., Giladi, N., & Hausdorff, J. M. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-008-0139-z · Cited by 193
Dystonia in Parkinson’s disease
Tolosa, E., & Compta, Y. (2006) · Journal of Neurology · doi:10.1007/s00415-006-7003-6 · Cited by 176
Deep Brain Stimulation: A Paradigm Shifting Approach to Treat Parkinson's Disease
Hickey, P., & Stacy, M. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00173 · Cited by 125
Current applications and limitations of surgical treatments for movement disorders
Krack, P., Martinez‐Fernandez, R., del Alamo, M., & Obeso, J. A. (2017) · Movement Disorders · doi:10.1002/mds.26890 · Cited by 122
“Indeed, long-term follow-up studies of DBS indicate that cognitive decline after surgery is part of the natural evolution of the disease rather than a side effect of stimulation.(46,53,55,130) The overall preference of the STN over the GPi resulted in a growing number of reports on STN-DBS–related cognitive and behavi…”
BackgroundSelf-citationNear‐infrared light is neuroprotective in a monkey model of Parkinson disease
Darlot, F., Moro, C., El Massri, N., Chabrol, C., Johnstone, D. M., Reinhart, F., Agay, D., Torres, N., Bekha, D., Auboiroux, V., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24542 · Cited by 114
Self-citationMorgante, L., Morgante, F., Moro, E., Epifanio, A., Girlanda, P., Ragonese, P., Antonini, A., Barone, P., Bonuccelli, U., Contarino, M. F., et al. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.12.013 · Cited by 94
Deep brain stimulation: current and future perspectives
Awan, N. R., Lozano, A., & Hamani, C. (2009) · Neurosurgical Focus · doi:10.3171/2009.4.focus0982 · Cited by 83
Leung, T. C. H., Lui, C. N. P., Chen, L. W., Yung, W. H., Chan, Y. S., & Yung, K. K. L. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn200072h · Cited by 78
Mundt, A., Klein, J., Joel, D., Heinz, A., Djodari‐Irani, A., Harnack, D., Kupsch, A., Orawa, H., Juckel, G., Morgenstern, R., et al. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06777.x · Cited by 80
Targeting the Progression of Parkinsons Disease
George, J., Mok, S., Moses, D., Wilkins, S., Bush, A., Cherny, R., & Finkelstein, D. (2009) · Current Neuropharmacology · doi:10.2174/157015909787602814 · Cited by 77
Long-term follow-up of deep brain stimulation for refractory obsessive-compulsive disorder
Roh, D., Chang, W. S., Chang, J. W., & Kim, C.-H. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.06.018 · Cited by 66
How do you treat motor complications in Parkinson's disease: medicine, surgery, or both?
Fahn, S. (2009) · Annals of Neurology · doi:10.1002/ana.21453 · Cited by 66
Flores Alves Dos Santos, J., Tezenas du Montcel, S., Gargiulo, M., Behar, C., Montel, S., Hergueta, T., Navarro, S., Belaid, H., Cloitre, P., Karachi, C., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0174512 · Cited by 54
A Systematic Review of Neuromodulation Treatment Effects on Suicidality
Kucuker, M. U., Almorsy, A. G., Sonmez, A. I., Ligezka, A. N., Doruk Camsari, D., Lewis, C. P., & Croarkin, P. E. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.660926 · Cited by 25
Metadata
- Authors
- Krack, P., Batir, A., Van Blercom, N., Chabardes, S., Fraix, V., Ardouin, C., Koudsie, A., Limousin, P. D., Benazzouz, A., LeBas, J. F., Benabid, A.-L., & Pollak, P.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-11-13
- Volume
- 349
- Issue
- 20
- Pages
- 1925-1934
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2095270577
- Cited by
- 2,249
- References
- 43
- FWCI
- 55.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.